DARPA Funds Six Organizations to Support Next-Generation Nonsurgical Neurotechnology program

The Next-Generation Nonsurgical Neurotechnology (N3) program.

Image: Freepik

The U.S. Defense Advanced Research Projects Agency (DARPA) has awarded funding to six organizations to support the Next-Generation Nonsurgical Neurotechnology (N3) program. The groups will attempt to develop high-resolution, bidirectional brain-machine interfaces that match the performance of implanted electrodes without the need for surgery.

The six organizations are: Battelle Memorial Institute, Carnegie Mellon University, Johns Hopkins University Applied Physics Laboratory, Palo Alto Research Center (PARC), Rice University, and Teledyne Scientific.

Related New Method of Deep Brain Stimulation Adapts to Patient’s Changing Needs

The wearable interfaces could ultimately enable diverse national security applications such as control of active cyber defense systems and swarms of unmanned aerial vehicles, or teaming with computer systems to multitask during complex missions, reports DARPA.

“DARPA is preparing for a future in which a combination of unmanned systems, artificial intelligence, and cyber operations may cause conflicts to play out on timelines that are too short for humans to effectively manage with current technology alone,” said Al Emondi, the N3 program manager. “By creating a more accessible brain-machine interface that doesn’t require surgery to use, DARPA could deliver tools that allow mission commanders to remain meaningfully involved in dynamic operations that unfold at rapid speed.”

In the past 18 years, the agency has showed success in neural control of prosthetic limbs and restoration of the sense of touch to the users of those limbs, relief of otherwise intractable neuropsychiatric illnesses such as depression, and improvement of memory formation and recall. Due to the inherent risks of surgery, these technologies have so far been limited to use by volunteers with clinical need.

Nonsurgical interfaces are needed by the military’s able-bodied population to benefit from neurotechnology. Similar technology could also greatly benefit clinical populations. By removing the need for surgery, N3 systems seek to expand the pool of patients who can access treatments such as deep brain stimulation to manage neurological illnesses.

Related British Army Exploring Utilization of Wearable Technology for Injury Prevention

“If N3 is successful, we’ll end up with wearable neural interface systems that can communicate with the brain from a range of just a few millimeters, moving neurotechnology beyond the clinic and into practical use for national security,” Emondi said. “Just as service members put on protective and tactical gear in preparation for a mission, in the future they might put on a headset containing a neural interface, use the technology however it’s needed, then put the tool aside when the mission is complete.”

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Autodesk, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, and many more. Register now to be part of #WTUS19

Sam Draper
May 28, 2019

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Fossil Launches New Stylish Hybrid Watch HR Monroe for Women

Fossil has launched a new version of its Hybrid HR line, the HR Hybrid Monroe. Designed...

STRAP Technologies Announces Groundbreaking Hands-Free Device to Replace Cane for the Visually Impaired

STRAP Technologies announced today, on White Cane Safety Day in the United States, the creation...

Bristol-Myers Squibb-Pfizer Alliance and Fitbit Collaborate on AFib Diagnosis

Wearable device maker Fitbit and pharmaceutical giants Bristol-Myers Squibb and Pfizer...

Apple Gets FDA Clearance for its Updated Version of ECG to Detect AFib

An updated version of Apple’s ECG feature received FDA clearance, allowing it to add abnormal...
Discover more